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Abstract
Background: Nutritional status in early life is critically involved in the metabolic phenotype of offspring. However
the changes triggered by maternal consumption of high-fat diet (HFD) in pre- or postnatal period should be better
understood. Here we evaluated whether maternal HFD consumption during gestation and lactation could differently
affect liver miR-122 and miR-370 expression leading to metabolic damages observed in offspring. Moreover, we
investigate whether early overnutrition program offspring to more harmful response to HFD in later life.
Methods: Female mice were fed either a standard chow (SC) diet or a HFD three weeks before and during mating,
gestation and/or lactation. Offspring were evaluated on the delivery day (d0), in a cross-fostering model at day 28 (d28)
and in adult life, after a re-challenge with a HFD (d82).
Results: In vitro analysis using liver cell line showed that palmitate could induced decrease in miR-122 and increase in
miR-370 expression. Newborn pups (d0) from obese dams showed a decrease in lipid oxidation markers (Cpt1a and
Acadvl), an increase in triacylglycerol synthesis markers (Agpat and Gpam), as well as lower miR-122 and higher miR-370
hepatic content that was inversely correlated to maternal serum NEFA and TAG. Pups fostered to SC dams presented
an increase in body weight and Agpat/Gpam expression at d28 compared to pups fostered to HFD dams and an
inverse correlation was observed between miR-122 hepatic expression and offspring serum TAG. In adult life (d82), the
reintroduction of HFD resulted in higher body weight gain and hepatic lipid content. These effects were accompanied
by impairment in lipid and glucose metabolism, demonstrated by reduced Cpt1a/Acadvl and increased Agpat/Gpam
expression, lower glucose tolerance and insulin sensitivity.
Conclusion: Our data suggest that both gestational and lactation overnutrition results in metabolic changes that can
permanently alter lipid homeostasis in offspring. The presence of fatty acids in maternal blood and milk seem to be
responsible for modulating the expression of miR-122 and miR-370, which are involved in liver metabolism. These
alterations significantly increase susceptibility to obesity and ectopic lipid accumulation and lead to a more harmful
response to HFD in offspring.
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Background
Nutritional status in early or pre-natal life is critically in-
volved in susceptibility to cardiovascular and metabolic
diseases development, such as hypertension, dyslipid-
emia, hyperglycemia and obesity [1, 2], events which
characterize the metabolic syndrome. Non-alcoholic
fatty liver disease (NAFLD) has been considered the
hepatic manifestation of this condition and, additionally,
is one of the most common causes of liver diseases
worldwide [3–5]. The liver plays a central role in modu-
lating glucose homeostasis and lipid metabolism, and
NAFLD is caused by an imbalance in lipid metabolism
pathways involved in triacylglycerol synthesis, export,
delivery, and oxidation [6, 7].
Recent studies demonstrated that increased adiposity,
hepatic insulin resistance and ectopic fat accumulation
have been associated with maternal body weight gain
and exposure to a high-fat diet (HFD) along critical
phases of development, such as gestation and lactation
[8–11]. Moreover, offspring exposed to a HFD in utero
and through lactation presents impaired hepatic mito-
chondrial function and up-regulation of lipogenesis, fac-
tors that may contribute to the development of NAFLD
and to the progression to a more aggressive liver disease,
the non-alcoholic steatohepatitis (NASH) [12].
It is known that lipids can act as signaling mole-
cules and transcriptional activators, and hepatic gene
transcription regulation by fatty acids was first re-
ported in 1990s [11, 13, 14]. Saturated fatty acids
(SFA), particularly, induce hypothalamic inflammation,
endoplasmatic reticulum stress, deleterious effects on
blood lipid and lipoprotein profile and, in the liver,
can bind to nuclear receptors of transcriptional fac-
tors involved in lipid homeostasis and induce lipid
droplet accumulation [15, 16].
Perinatal exposure to fatty acids overload, specially
SFA, may trigger epigenetic mechanisms that regulate
genes involved in lipid sensing and metabolism [11].
MicroRNAs (miRNAs) are epigenetic modulators of
gene expression that acts as mRNA silencers, and their
regulation are reported to be involved in almost all bio-
logical processes in animals [17, 18]. In contrast, studies
have shown that multiple factors can interfere in miRNA
expression, such as toxic, chemical and environmental
agents and also dietary components [19]. miR-122 and
miR-370 participate in the regulation of hepatic lipid
metabolism [20–26]. miR-122 is predicted to modulate
lipogenic genes and to be potentially targeted by miR-
370 which, in turn, can directly bind to carnitine palmi-
toyltransferase 1α (Cpt1a) gene [20, 21].
In a recent study, we showed that maternal HFD con-
sumption during pregnancy and lactation leads to a de-
creased miR-122 and increased miR-370 expression in
the liver of recently weaned mice [25]. These miRNAs
alterations occurred concurrently with higher expression
of lipogenic genes (Gpam, Agpat and Scd1) and lower
expression of genes related to fatty acid oxidation (Cpt1a
and Acadvl) [25]. However, although our previous re-
sults reports that miR-122 and miR-370 may participate
in the genesis of metabolic damage associated to fatty
liver [25], it is not possible to assign the role of gesta-
tional or lactational periods to the effects observed in
offspring from obese dams and literature data concern-
ing these phenomena are very controversial.
Using a cross-fostering model, Oben and co-workers
(2010) showed that lean offspring suckled by obese dams
presents increased body weight and food consumption,
along with metabolic complications evidenced by in-
creased insulin and leptin levels in plasma and develop-
ment of NAFLD in adulthood [27]. In contrast, other
studies suggest that health status in adulthood is primar-
ily determined by the conditions under which an organ-
ism develops in the womb. Gniuli and colleagues [28]
showed that exposure to a HFD in utero may lead off-
spring to a type 2 diabetes phenotype, which could even
be transmitted to the progeny. Moreover, maternal con-
sumption of HFD during pregnancy was reported to
cause a dysregulation in triglyceride metabolism and, in
adipose tissue, to lead to increasing in leptin and sup-
pression of adiponectin levels through epigenetic modifi-
cations, leading offspring to a metabolic syndrome-like
phenomenon [29].
Importantly, it was previously shown that the meta-
bolic alterations in offspring from HFD fed dams dur-
ing gestation and suckling period, such as leptin and
insulin resistance and ectopic fat accumulation in the
liver, persists into adult life, even when they are
maintained on a healthy standard chow diet after
weaning [10]. However, the molecular mechanism as-
sociated to hepatic lipid metabolism modification and
the development of fatty liver in adult offspring from
HFD fed dams still need to be clarified.
Additionally, another question is still to be answered:
which stimulus present at gestational and/or lactational
period would be responsible for triggering metabolic
programming of offspring from obese dams? The major-
ity of experimental protocols used to study the foetal
programming by maternal obesity consist of inducing
weight gain through a HFD consumption. During preg-
nancy, nutrients are transported from maternal circula-
tion to the fetuses via the placenta and, at suckling
periods, maternal diet directly affects milk composition
[30–34]. Therefore, we hypothesized that the excessive
maternal lipids, particularly SFA, could be the trigger for
the miRNAs modulation that we earlier reported in the
liver of offspring [25].
Thus, the aim of the present study was to test the hy-
pothesis that maternal high fat diet could directly
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modulate miR-122 and miR-370 expression and to in-
vestigate the independent contribution of pregnancy
and lactation to the altered hepatic lipid metabolism
observed in young offspring from obese dams. Add-
itionally, we also evaluated whether this metabolic
programming would persist to adulthood and, more-
over, whether offspring from HFD-fed dams would
present increased metabolic complications after a re-
challenge to nutritional overload in adult life.
Methods
In vitro analysis
HepG2 human hepatocyte cell line was kindly provided
by Dr. Gabriel Forato Anhe, from Farmacology Depart-
ment of Medical Sciences Faculty of State University of
Campinas. Hepa1c1c7 mouse hepatocyte cell line was
purchased from BCRJ (Rio de Janeiro Cell Bank, Brazil).
HepG2 was maintained in DMEM (Dulbecco’s modi-
fied Eagle’s Medium) and Hepa1c1c7 in α-MEM
(Minimum Essential Medium Eagle without nucleo-
sides), both supplemented with 10% FBS, 100U/mL
penicillin and 0,1 mg/mL streptomycin, incubated at
37 °C in 5% CO2. Experiments were performed be-
tween passages 5 and 40.
Cells were grown as monolayers at a density of 4 ×
105 cells/mL and two days after seeding, the cultured
cells were treated for 6 h with Palmitate (Sigma
Aldrich) 500 μM or Palmitate vehicle (NaOH + BSA,
3:1) as a control.
Animals
Five weeks old virgin female and male Swiss mice (Mus
musculus) were obtained from the Animal Breeding
Center at the University of Campinas (Campinas, São
Paulo, Brazil) for mating. The general experimental
design is illustrated in Fig. 1.
Female mice were randomly fed either HFD or stand-
ard chow diet (SC) ad libitum for three weeks before
mating (adaptation period). HFD was prepared accord-
ing to Benatti et al. [25] (Table 1).
Adult males were fed only SC during the adapta-
tion period. Mating was performed by housing
females for three days with males. Pregnancy was
confirmed by examination of vaginal smears for the
presence of sperm.
Pregnant females were maintained in individual poly-
propylene micro-isolators, at 22 ± 1 °C and lights on
from 06.00 to 18.00 h. The same diet offered before mat-
ing was maintained during gestation period. The study
was performed following two protocols: one of them was
used to evaluate the effect of maternal overnutrition on
offspring metabolism, during gestation or lactation; the
other protocol was used to evaluate the metabolic
complication in offspring from high fat dams after re-
challenge to adult life in nutritional overload (Fig. 1).
To the first protocol on day 0 (d0, first post-partum
day), litters were divided in two groups according to ma-
ternal diet: offspring from female mice fed SC were
called C and those from female mice fed HFD were
called H. Some litters were euthanized and used for d0
analysis. The remaining litters were adjusted to eight
pups each to ensure a standard litter size per mother
and were followed until d28 (Fig. 1a).
To study the effect of maternal exposure to HFD on
offspring metabolism, during gestation or lactation sep-
arately, we carried out the cross-fostering protocol. At
d0, individual pups from the litters were randomly
assigned to two different foster conditions: (a) un-
fostered (i.e. the pups were fed by their own mother)
and (b) cross-fostered (i.e. the pups were fostered by a
mother from the other group). Four groups were ob-
tained: CC and HH, in which pups were exposed to SC
or HFD during gestation and lactation, respectively, and
HC and CH, in which pups were exposed to HFD only
during gestation or only during lactation, respectively
(Fig. 1b). All pups were weaned on day 18 and separated
according to sex. Only males were used to perform the
analysis. The cross-fostered (CH and HC) and un-
fostered (CC and HH) groups were fed exclusively an SC
diet after weaning until experimental day 28 (d28).
To the second protocol the un-fostered pups from CC
and HH groups were maintained on SC diet after wean-
ing until day 42 (d42). Part of the litters remained on
standard chow diet until day 82 (CC and HH) and the
other part were re-challenged with a HFD until day 82
(CC-HF and HH-HF) (Fig. 1c).
Females in adaptation, gestation or lactational periods
were fed growth HFD to ensure an adequate protein
supply, while offspring exposed in adult life (CC-HF and
HH-HF) were fed maintenance HFD (Table 1).
The total number of animals used in each experiment
is mentioned in the figure legends.
Body composition
Body weight was measured weakly for dams and pups.
To estimate the body fat in d0 groups, we measured
naso-anal length of pups, and Lee Index of Obesity
(LIO) was calculated using the formula: body weight (g)
(1/3) / naso-anal length (cm). To measure adiposity in
dams, d28, d42, and d82 groups, white adipose tissue
(epidydimal and retroperitoneal) was collected and
weighted after sacrifice, and the percentage of adiposity
normalized by total body weight was calculated.
Food intake
Food intake was estimated for dams (at gestational day
12 and lactation day 15), d28, d42, and d82 groups
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during 24 h over a period of four days. The average was
considered as food intake (Kcal/d).
Biochemical analysis
To evaluate triglycerides (TAG) and cholesterol (CHOL)
levels, blood samples were collected on the experimental
days after overnight fasting. By enzymatic colorimetry,
serum aliquots were used to measure the levels of TAG
and cholesterol.
To evaluate fasting glucose, blood samples were col-
lected after overnight fasting by decapitation or from the
tail. Glycaemia was determined on an Accu-Chek
Performa glucometer.
To determine serum insulin and leptin, blood samples
were collected on the experimental days after overnight
fasting. Serum insulin were determined using Rat/Mouse
Insulin Kit from Millipore and serum leptin were deter-
mined using Mouse Leptin ELISA kit.
Hepatic total lipids content was evaluated as proposed
by Folch and colleagues [35].
Fig. 1 Experimental Protocol. Experimental protocol followed to investigate the effect of maternal overnutrition on offspring metabolism, during
gestation or lactation. Offspring of control (C-D) and HFD (HF-D) dams were evaluated at d0 (C and H) and d28 (CC, CH, HH and HC) (a). Details
of the protocol followed to obtain cross-fostered groups (b). Experimental protocol followed to evaluate the metabolic complication in offspring
after re-challenge to adult life in nutritional overload at d82 (CC, CC-HF, HH, and HH-HF) (c)
Table 1 Nutritional composition of the standard chow and
experimental diets offered to mice during adaptation, gestation,
lactation and post-natal life
SC Dieta Growth HFD Maintenance HFD
Net Protein (g %) 20b 23,3c 16,7c
Fat Content (g %) 4d 24e 24e
Carbohydrates (g %) 65,95f 42,1f 49,3f
Fiber (g %) 5 5,55 5
Mineral Mix (g %) 3,5 3,5 3,5
Vitamin Mix (g %) 1 1 1
Choline (g %) 0,25 0,25 0,25
Cystine (g %) 0,3 0,3 0,25
Total 100 100 100
Energy (KJ/g) 14,6 19,3 19,3
aNUVILAB® Cr-1; Nuvital
bvegetal protein - from wheat and corn (added lysine and methionine)
canimal protein - casein
dsoy oil
esoy oil and lard
fstarch and saccharose
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Intraperitoneal Glucose, Insulin and Pyruvate Tolerance
Test (GTTip, ITTip and PTTip)
Tolerance tests were performed in adult offspring exposed
to a HFD and the same animals were used for all tests,
with an interval of at least one week between each test.
Glycaemia was determined in an Accu-Chek Performa
Glucometer (Roche Diagnostics, Basel, Switzerland). Pyru-
vate tolerance test was performed to more directly assess
the role of HFD in hepatic glucose homeostasis in adult
offspring from obese dams.
For the glucose (GTT) and insulin (ITT) tests, mice
were starved for 12 h, fed for h and starved for 4
additional hours before intraperitoneal (IP) injections.
For GTT, a solution of 25% D-glucose was used and
each animal was injected with 1 g/kg of glucose.
Glycaemia was measured at 0, 15, 30, 60, 90 and
120 min after glucose administration. For ITT, recom-
binant regular insulin (1,5 UI/kg, Humulin®, Eli Lilly
and Company, EUA) was administrated by IP injec-
tion and glycaemia was measured at 0, 3, 6, 9, 12 and
15 min after injection.
For the pyruvate (PTT) test, mice were starved for
12 h and fed for 2 h, and the test was performed in fed
state. IP injection of a pyruvate solution (20%) was ad-
ministered in a dose of 2 g/kg and glycaemia was mea-
sured at 0, 15, 30, 60, 90 and 120 min after pyruvate
administration.
In both GTT and PTT, results are presented as area
under curve (AUC) of glycaemia vs. time, above each in-
dividual baseline. In ITT, results are presented as kITT,
the constant for the glucose clearance rate, calculated
using the formula 0,693/t1/2.
Quantitative Real-Time PCR (qRT-PCR)
Total hepatic RNA was extracted from liver (150 mg),
using TRIzol reagent according to the manufacturer’s
recommendations and quantified using NanoDrop ND-
2000. Reverse transcription was performed with 3 μg of
total RNA, using a high-capacity cDNA reverse
transcription kit (Thermo Fisher Scientific). Relative
expression was determined using a Taqman detection
system and primers for the target genes: Agpat1 (Mm
00479699_g1); Acadvl (Mm 00444293_m1); Cpt1a (Mm
01231183_m1); Gpam (Mm 00833328_m1) for liver ana-
lysis. Actin beta (β-Actin, Mm 02619580_g1) was used
as the endogenous control (Thermo Fisher Scientific).
Each PCR contained 20 ng of complementary DNA.
Real-time PCR was performed on an ABI Prism 7500
Fast platform. Data were analyzed using the sequence
detection system 2.0.5 and expressed as relative values
determined by the comparative threshold cycle (Ct)
method (2 − ΔΔCt) according to the manufacturer’s
recommendation.
Purification and quantification of miR
The miR content was extracted and purified from the
Hepa1c1c7 and HepG2 cells and from the liver (150 mg)
of the mice using the mirVana miRNA isolation kit
(Thermo Fisher Scientific) according to the manufac-
turer’s instructions. The relative expression of miR-122
and miR-370 (ID 002245 and ID 002275, respectively,
Thermo Fisher Scientific) was determined using primers
with a TaqMan detection system and U6 spliceosomal
RNA (ID 001973, Thermo Fisher Scientific) as endogen-
ous controls. Gene expression was accessed by real-time
PCR performed on the ABI Prism 7500 Fast platform
and analyzed according to 2.5.
Statistical analysis
Numeric results are expressed as means with their
standard errors of the indicated number of experiments.
Student’s t-test was used for unpaired samples and ana-
lysis of variance (ANOVA) for multiple comparisons. A
post-hoc test (Bonferroni) was used to determine a sig-
nificance level of p ≤ 0.05. Pearson’s correlations were
used to determine the relation between miR-122 expres-
sion and serum TAG or NEFA and a linear regression ±
95% confidence interval analysis were performed. In all
cases, the statistical significance was set at p ≤ 0.05. The
statistical analyses used in each table and graph are
specified in the respective legend.
Results
In vitro hepatocytes treatment with palmitate alters miR-
122 and miR-370 levels
To test the hypothesis that fatty acids could modulate
the expression of hepatic miR-122 and miR-370, we
performed in vitro analysis in mouse (Hepa1c1c7) and
human (HepG2) hepatoma cell lines treated with
palmitate. The treatment lead to a decreasing in miR-
122 (among 13 to 39%) and an increasing in miR-370
levels (among 31 to 114%; Fig. 2a and b, respectively),
indicating that excessive fat could alter the expression
of these miRNAs in liver.
Maternal HFD consumption in gestational period leads
newborn offspring to altered miRNAs and lipid-related
gene expression in the liver
Next, our goal was to evaluate in which moment - preg-
nancy or lactation - maternal excessive lipids would be
responsible for the modulation of the miRNAs in off-
spring. For this purpose, we evaluated pups from HF-D
and C-D in the day of delivery (d0).
HFD consumption lead dams to alterations in body com-
position, impaired serum parameters and hepatic total
lipids accumulation at gestational period (Additional file 1:
Figure S1). Mice from dams fed HFD during gestation (H)
showed lower body weight and LIO (Fig. 3a and b,
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respectively) in comparison to offspring from control dams
(C). The serum levels of CHOL and TAG in C and H
groups were very similar (Fig. 3c). However, we observed
that H presented higher fasting glucose levels (9% more
than C) immediately after birth, but the same insulin levels
compared to C (Fig. 3d and e, respectively).
Mice from H group had reduced Cpt1a (38.5-fold) and
Acadvl (5.6-fold; Fig. 3f ) gene expression. An increase in
Agpat (1.3-fold) and Gpam (1.9-fold; Fig. 3g) gene ex-
pression was also observed in offspring of obese dams.
Moreover, maternal consumption of a HFD during
gestation provoked a decrease in miR-122 (50%) and an
increase in miR-370 (206%) expression (Fig. 3h). Inter-
estingly, liver miR-122 expression in newborn offspring
was inversely correlated with maternal serum TAG levels
(p = 0.0016 - Fig. 3i).
Maternal HFD consumption in gestational or suckling
periods independently alters miR-122 and miR-370 and
lipid-related gene expression in the liver of recently
weaned offspring
To evaluate whether hepatic modulation of miR-122 and
miR-370 by maternal HFD at gestational period would
persist after weaning and to investigate if maternal milk
would exert a similar effect, we fostered pups after birth.
The alterations observed in body composition and
serum biomarkers of HFD-fed dams at gestation per-
sisted to lactation period (Additional file 1: Figure S1).
At d28, we observed an increase in body mass in pups
gestated, suckled or both by dams fed HFD compared to
those gestated and suckled by control dams, since CH,
HH, and HC showed a higher body weight than CC
(Fig. 4a). However, despite CH showed a raise in adipos-
ity in comparison to CC, alterations in the gestational
period seem to be more harmful to offspring's body
composition, since both HH and HC groups presented
the highest levels of adiposity (Fig. 4b). Caloric intake
was elevated in CH (20%), HH (21%) and HC (20%;
Fig. 4c) as well as fasting glucose for the same groups
in comparison to CC (1.6-, 1.7- and 1.7-fold, respect-
ively) (Fig. 4d).
Serum CHOL and TAG levels were higher in HH in
comparison to CC (1.3-fold). Furthermore, among the
cross-fostered mice, HC showed higher CHO and TAG
levels than CH (1.3- and 1.5-fold, respectively - Fig. 4e).
The relative expression of oxidative (Cpt1a and
Acadvl) and lipogenic genes (Agpat and Gpam) in
liver was assessed in crossfostered and unfostered off-
spring. Interestingly Cpt1a expression in HH was re-
duced (46%) compared to CC (Fig. 4f ), suggesting
reduction in fatty acid oxidation in this group. How-
ever, no differences in crossfostered groups were ob-
served. However, Acadvl expression, another marker
of fatty acid oxidation, was significantly reduced in
unfostered HH (35%), as well as in crossfostering
groups (CH and HC) (Fig. 4f ).
Additionally, as showed in Fig. 4g, either Agpat or
Gpam, both genes involved in triglycerides synthesis
pathway, were increased in HH (62% and 33%, respect-
ively) and CH (87% and 38%, respectively), but they were
significantly higher in HC (164% and 62%, respectively),
another indicative of the detrimental effect of diet on
gestational period. HH presented an increasing in hep-
atic total lipid content (173%) despite HC have shown a
tendency to increasing in this parameter when compared
to CC and CH (Fig. 4h).
Interestingly, hepatic miR-122 expression was signifi-
cantly reduced in CH (2.2-fold), HH (1.5-fold) and HC
(2.1-fold) compared to CC, while mir-370 expression
was significantly increased in CH (4.4-fold), HH (7.7-
fold) and HC (8.9-fold) (Fig. 4i), corroborating the data
showing that HFD feeding at gestational period leads to
alterations in these miRNAs in offspring and also show-
ing that excessive lipids consumption at lactation period
can also lead to these miRNAs modulation. Moreover,
miR-122 expression in the liver of recently weaned off-
spring showed inversely correlation with serum TAG
levels (Fig. 4j).
Fig. 2 Fatty acid exposure induces miRNAs modulation in mouse and human liver cell lines. MicroRNA level (qRT-PCR) - miR-122 and miR-370 -
from Hepa1c1c7 mouse hepatoma cell line (1x108cells/mL) (a) and HepG2 human hepatoma cell line (1x108cells/mL) (b) 6hs after exposure to
palmitic acid (500uM). For relative gene expression analysis, U6snRNA was used as endogenous control. Values are means (n = 3–6) + - SEM.
Student's t-test was used to compare Control and Palmitic Acid groups. Different letters indicate statistical significance between groups (p≤ 0.05)
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Fig. 3 (See legend on next page.)
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Metabolic programming and hepatic miRNAs modulation
by maternal HFD consumption in gestation and lactation
persists into adult life of offspring
To investigate whether the metabolic phenotype and
hepatic miRNAs modulations observed previously [25]
and reported here in CC and HH d28 offspring would
persist into adult life, we evaluated the same parameters
at d82. Body composition of HH remained altered, since
body weight (11.5%) and adiposity (35%) were higher in
this group in comparison to CC (Fig. 5a and b, respect-
ively), although food intake was not different between
the groups (Fig. 5c). Fasting glucose was also higher in
HH (1.4-fold) at d82 (Fig. 5d). Hepatic gene expression
analysis showed that, besides Cpt1a did not differ,
Acadvl expression was still decreased in HH (19% -
Fig. 5e) and, moreover, Agpat expression remained
highly increased (63%), although Gpam was not signifi-
cantly different between CC and HH (Fig. 5f ). CHOL
levels were not changed, but TAG levels were higher
(1.1-fold - Fig. 5g) and total hepatic lipids were increased
in HH (1.1-fold - Fig. 5h).
Importantly, the modulation of hepatic miRNAs by
maternal HFD consumption at gestation and lactation
also persists to adult life, since HH showed lower miR-
122 (42%) and higher miR-370 (139%) expression in
comparison to CC at d82 (Fig. 5i).
Maternal HFD consumption at gestation and lactation
leads offspring to increased metabolic complications
when exposed to a HFD in adult life
Finally, we evaluated whether an HFD exposure in early
life and its consequent modulation of key hepatic miR-
NAs would increase HFD sensitivity in later life and
negatively affect lipid and glucose metabolism in off-
spring, we used a model in which offspring from obese
and lean dams were re-challenged to HFD.
At d42, we investigated some parameters of offspring
prior to exposure to HFD in order to observe whether
the phenotype of HH group remained different from CC
group, as observed on d28. Compared to CC, HH were
still heavier (10%) and presented higher fat mass (38%)
(Additional file 2: Figure S2A and B, respectively), al-
though caloric intake between groups was not different
(Additional file 2: Figure S2C). HH presented impaired
glucose homeostasis with more elevated fasting glucose
(1.3-fold) and insulin (1.2-fold) than CC (Additional file 2:
Figure S2D and E, respectively). Moreover, TAG levels
were higher in HH, despite CHOL serum levels were
not different between the groups (Additional file 2:
Figure S2F).
After HFD exposure for over five weeks, HH–HF pre-
sented a significantly higher weight gain, as early as the
first week of HFD consumption, and an increased total
body mass (11%) in comparison to CC–HF (Fig. 6a and
b, respectively). Adiposity was also increased in HH-HF
(35%), as well as food intake (1.2-fold) (Fig. 6c and d,
respectively).
Serum parameters reveals higher levels of CHOL,
TAG, leptin and fasting glucose in HH-HF (Fig. 6e and
f) and, moreover, tolerance tests showed that HH-HF
presented disturbances in glucose homeostasis, since
these group presented higher AUC in GTT (45%) and
PTT (36%) and diminished glucose clearance as shown
in kITT (5.7-fold - Fig. 6g, h and i, respectively).
Besides no differences were observed in Acadvl, Cpt1a
expression was decreased in HH-HF liver (Fig. 6j) and,
furthermore, Agpat and Gpam expression were mark-
edly increased (242% and 161%, respectively - Fig. 6k).
Additionally, HH-HF presented higher levels of hepatic
total lipid content when in consumption of a HFD than
CC-HF (18.5% - Fig. 6l).
Discussion
Maternal consumption of HFD during critical develop-
mental periods has been shown to lead to commitments
on offspring's homeostasis and may result in metabolic
disorders [11, 28]. We recently showed that maternal
consumption of HFD during gestation and lactation acti-
vates pro-inflammatory pathways and unfolded protein
response, impairs cholinergic anti-inflammatory path-
way, modulates autophagy proteins and also affects lipid
metabolism in offspring [25, 36–38]. Offspring from
HFD-fed dams present downregulation of hepatic β-oxi-
dation-related genes and upregulation of genes involved
in lipid synthesis, and these alterations seem to be driven
by the modulation of miR-122 and miR-370 levels, caus-
ing metabolic adaptations that lead to increased ectopic
lipid accumulation in the liver of recently weaned mice
[25].
Despite some studies have suggested that maternal
macronutrients may be responsible for gene expression
modulation in foetal offspring [39–41], we have not
(See figure on previous page.)
Fig. 3 Maternal HFD consumption at gestation period leads newborn offspring to altered miRNAs and lipid metabolism-related gene expression.
Body weight (a), lee index of obesity (LIO) (b), serum lipids (CHOL and TAG - c), fasting glucose (d) and serum insulin (e), mRNA levels (qRT-PCR)
of hepatic Cpt1a and Acadvl (f), and Agpat and Gpam (g), microRNA level (qRT-PCR) of hepatic miR-122 and miR-370 (h) from newborn offspring
from C and H groups. Correlation analysis between hepatic miR-122 from d0 offspring vs. serum NEFA (i) and TAG (j) from dams. For relative gene
expression analysis, β-Actin and U6snRNA were used as endogenous controls. Values are means (n = 5–12) + - SEM. Student's t-test was used in all
analyses to compare C and H groups. Different letters indicate statistical significance between groups (p≤ 0.05)
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Fig. 4 Maternal HFD consumption at gestation or lactation independently alters miRNAs and lipid-related gene expression. Body weight (a), adiposity
(b), caloric intake (c), fasting glucose (d) and serum lipids (CHOL and TAG - e), mRNA levels (qRT-PCR) of hepatic Cpt1a and Acadvl (f), and Agpat and
Gpam (g), hepatic total lipid content (h), microRNA level (qRT-PCR) of hepatic miR-122 and miR-370 (i), correlation analysis between hepatic miR-122
and serum TAG (j) from recently weaned unfostered offspring (CC and HH) and crossfostered offspring (CH and HC) at d28. For relative gene
expression analysis, β-Actin and U6snRNA were used as endogenous controls. One-way ANOVA was used in all analyses to compare CC, CH, HH and
HC groups. Values are means (n = 5–8) + - SEM. Different letters indicate statistical significance between groups (p≤ 0.05)
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found studies showing that components of maternal diet
could directly alter miRNAs expression in offspring. It is
known that a HFD consumption increases lipids levels
in serum, such as TAG, CHOL and free fatty acids (FFA)
[25] and, moreover, maternal diet can directly affect
breast milk composition [32–34, 42]. Therefore we hy-
pothesized that the lipids consumed by the dams,
specially SFA, could be responsible for miR-122 and
miR-370 modulation in the liver of offspring through
placental delivery during gestation and/or milk compos-
ition during suckling period.
As shown in the present study, treatment with pal-
mitic acid, one of the most abundant SFAs in the human
diet and blood, leads to a decrease in miR-122 and in-
creased miR-370 levels in hepatocytes. It have been
largely reported that SFAs play an important role in the
development of insulin resistance by their directly regula-
tion of inflammatory and metabolic pathways [15, 16, 43].
Fig. 5 Metabolic programming and hepatic miRNAs modulation by maternal HFD consumption persists into adult life of offspring. Body weight
(a), adiposity (b), caloric intake (c), fasting glucose (d), mRNA levels (qRT-PCR) of hepatic Cpt1a and Acadvl (e) and Agpat and Gpam (f), serum
lipids (CHOL and TAG - g), total hepatic lipid content (h), microRNA level (qRT-PCR) of hepatic miR-122 and miR-370 (i) from adult offspring from
CC and HH groups at d82. For relative gene expression analysis, β-Actin and U6snRNA were used as endogenous controls. Values are means (n= 5–8) + -
SEM. Student's t-test was used in all analyses to compare CC and HH groups. Different letters indicate statistical significance between groups (p≤ 0.05)
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Fig. 6 (See legend on next page.)
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More recently, studies showed that several miRNAs are
dysregulated in rodent models of diet-induced obesity,
type 2 diabetes and NAFLD [44], reinforcing that exces-
sive fat consumption, particularly SFAs, may be involved
in miRNAs modulation that participate in the genesis of
metabolic diseases. Importantly, in vitro analysis showed
that miRNAs can be direct targets of dietary components,
including fatty acids [19, 45]. Moreover, Nie and col-
leagues (2014) induced lipid accumulation in human hep-
atocyte cell line using oleic acid. In this steatotic
hepatocyte model, miR-122 expression was downregulated
and, importantly, transfection with miR-122 mimic signifi-
cantly reduced lipids within the hepatocytes [46].
After confirming that the in vitro treatment with
palmitate was able to reduce miR-122 and increase miR-
370 expression, we aimed to investigate the independent
contribution of maternal excessive lipids consumption at
gestational or lactation periods on the modulation of
these miRNAs, since only few studies have investigated
the relative contribution of pre- or post-natal maternal
HFD consumption to metabolic phenotype in offspring.
Sun and colleagues [47] showed that maternal HFD con-
sumption during the suckling period has a high influ-
ence on leptin signaling in offspring. On the other hand,
Cerf and colleagues [48] showed that neonates ex-
posed to HFD only during foetal development pre-
sented reduced volume and number of β-cells,
accompanied by sustained and irreversible hypergly-
caemia during adulthood.
Here, we showed that pups from HFD-fed dams pre-
sents lower body weight and LIO at birth (d0), in com-
parison to pups from control dams. Similar studies have
shown higher body weight and macrosomia in newborns
from obese dams [49, 50] however, some authors have
shown reduced body weight in offspring at d0 using
models of maternal hyperglycemia and transient hyper-
insulinemia. In our model, HFD-fed dams presented
higher insulin levels prior to mating when compared to
control dams and, although this hormone does not cross
the placental barrier, some authors suggest that maternal
hyperinsulinemia may lead to placental disorders and
that this occurrence may be related to the delayed foetus
development [51–53].
Interestingly, besides the lower body weight, hepatic
lipid synthesis seems to be increased in offspring from
HFD-fed dams at birth, as suggested by liver Agpat and
Gpam levels and, in contrast, genes related to fatty acid
oxidation (Cpt1a and Acadvl) are reduced in their liver.
There are several evidences in humans indicating that
maternal obesity leads to increased fuel availability for
the foetus and may drive to increased hepatic fat storage
[54]. Maternal nutritional overload and placental transfer
is a challenge to foetal development and, as suggested by
Brumbaugh and Friedman [54], until final gestational
phases, subcutaneous fat is not available to act as a stor-
age buffer so, under dietary excesses, the foetal liver,
among another organs, becomes a fat deposit. McCurdy
and co-workers [55] showed, in non-human primates, an
increase in hepatic TAG and elevated hepatic expression
of gluconeogenesis key genes in foetus from HFD-fed
dams at gestational third trimester and the maternal
resistance to obesity development did not reduce the ef-
fects of the HFD-consumption on hepatic metabolism of
the fetuses. Therefore, these findings suggest that mater-
nal HFD consumption during pregnancy can modulate
lipid metabolism in offspring, favoring fat deposition.
As we have speculated, miR-122 and miR-370 may be
involved in the impairments of lipid homeostasis of new-
borns from HFD-fed dams, since we find here that these
miRNAs are modulated at d0, as early as the hepatic en-
zymes involved in lipid metabolism. Furthemore, mater-
nal FFA at gestation correlated directly with miR-370
and inversely with miR-122 in the liver of newborns,
thus reinforcing the hypothesis that maternal lipids that
cross placental barrier are able to modulate miRNAs
expression of offspring.
It have been shown that mice lacking the gene encod-
ing miR-122a are viable, but they develop hepatosteato-
sis, NASH and fibrosis and present hepatic infiltration of
inflammatory cells that produce pro-tumorigenic cyto-
kine, including IL-6 and TNFα, thus leading to the de-
velopment of hepatocellular carcinoma [22, 26, 56].
Besides, Hsu and colleagues (2012) showed that knock-
out mice for miR-122 in liver present higher expression
of several hepatic enzymes involved in TAG synthesis,
including Agpat [56]. Additionally, Xu and colleagues
showed that inhibition of miR-370 led to downregulation
of pro-inflammatory cytokines, suggesting that this
miRNA plays a pro-inflammatory role and may be re-
lated to hepatic damage [57]. Although the relationship
between the levels of miR-122 and miR-370 is still sub-
ject to debate [14, 19], we showed that there is an
(See figure on previous page.)
Fig. 6 Maternal HFD consumption leads offspring to increased metabolic complications when exposed to HFD in adult life. Weight gain (a), body
weight (b), adiposity (c), caloric intake (d), serum parameters (CHOL, TAG and leptin) (e), fasting glucose (f), area under curve (AUC) of GTT (g)
and PTT (h), glucose clearance during ITT (i), mRNA levels (qRT-PCR) of hepatic Cpt1a and Acadvl (j) and Agpat and Gpam (k), total hepatic lipid
content (l) from adult offspring after exposure to HFD for 40 days at d82 (CC-HF and HH-HF groups). For relative gene expression analysis, β-Actin
was used as endogenous control. Values are means (n = 5–8) + - SEM. Student's t-test was used in all analyses to compare CC-HF and HH-HF groups.
Different letters indicate statistical significance between groups (p≤ 0.05)
de Paula Simino et al. Nutrition & Metabolism  (2017) 14:16 Page 12 of 15
inverse expression of these miRNA in our model at dif-
ferent ages. Thus, considering the impact of lipid metab-
olism and inflammatory signaling on the development of
NAFLD, maternal HFD consumption during the gesta-
tional period could be considered an important risk
factor for liver diseases in offspring.
Using the cross-fostering model, we were able to fur-
ther confirm the importance of maternal HFD consump-
tion during gestation to hepatic lipid metabolism and
also investigate whether the suckling period would exert
the same effect. Surprisingly, miR-122 and miR-370
levels seem to be also modulated by maternal milk, since
pups from control dams suckled by HFD-fed dams
showed a decrease in miR-122 and increased expression
of hepatic miR-370 as well as upregulation of TAG syn-
thesis markers (Agpat and Gpam) and downregulation
of a fatty oxidation marker (Acadvl). Regardless of the
negative effects of HFD consumption at gestational
period seem to be more pronounced, in general, the im-
pairments in lipid homeostasis observed at gestation are
also present at the suckling period by itself. Although we
did not evaluate milk composition, previous studies
demonstrated that HFD consumption and mainly the
availability of plasma fatty acid for uptake by the mam-
mary gland alters the fatty acid composition and con-
tent, specially medium chain fatty acids secreted in milk
of human and rat [42, 58, 59], and may exert effects on
the fat accumulation in the neonatal liver.
Besides, offspring from HFD-dam presents altered
serum lipid levels [25] and here, offspring's serum TAG
correlated directly with miR-370 and inversely with miR-
122 hepatic expression.
Given that we showed that excess maternal lipids at
both gestational and lactation periods are independently
able to alter hepatic miRNAs in newborn and recently
weaned offspring, respectively, that may lead to impaired
lipid metabolism, the next step was to investigate
whether these modulation would persist into adult life.
As shown here and previously, offspring exposed to ma-
ternal HFD at gestation and lactation still present, at
d82, increased body weight, adiposity, fasting glucose
and fat accumulation within the liver. Interestingly, adult
offspring from HFD-fed dam still shows decreased miR-
122 and increased miR-370 expression in the liver. These
findings suggest that epigenetic modifications at pre and
recent post-natal life are persistent. Thorn and col-
leagues (2014) also showed that, in non-human primates,
maternal insulin resistance induced by HFD consumption
at developmental stages negatively and irreversible affects
hepatic immune system and development of de novo lipo-
genic pathways [60]. For these reasons, authors believes
that exposure to excess maternal lipids at critical develop-
ment periods may be considered the "first hit" for the
pathogenesis of liver diseases [60, 61].
The "two hits" or "multiple hits" hypothesis was postu-
lated as an attempt to explain the mechanisms under-
lying the progression of NAFLD to more aggressive liver
diseases, such as NASH and fibrosis. Ectopic accumula-
tion of fat in the liver, the steatosis, was considered the
"first hit", and authors suggested that a second hepatic
insult, such as oxidative stress or drugs, would be neces-
sary to lead to chronical inflammation and NAFLD pro-
gression [62, 63]. Nowadays, it is hypothesized that the
obesity and lipid overload in intra-uterine environment
could program the foetal liver and trigger the "first hit"
and, afterwards, a high-fat diet consumption in post-
natal life would be enough to lead to hepatic inflamma-
tion and to liver diseases progression [61].
In this context, we showed here that offspring chal-
lenged with maternal lipid overload in pre-natal life and
through lactation present a more deleterious response
when exposed to a HFD in adult life, by showing an in-
crease in weight gain, adiposity and serum parameters,
such as CHOL, TAG, leptin and fasting glucose and,
moreover, exacerbated glucose homeostasis disturbances
and lipid accumulation in the liver, factors that may lead
to inflammatory pathways activation. We showed re-
cently that glucose homeostasis disturbances observed in
adult offspring re-challenged to HFD may occur due to
an imbalance in insulin signaling in peripheral tissues
(such as visceral adipose tissue) and hypothalamus.
Additionally a failure in glucose production blockade in
the liver was also observed [64]. Therefore, since insulin
resistance plays a central role in the metabolic syndrome
and the ectopic lipid accumulation in the liver has been
considered the hepatic manifestation of this condition
[4, 5], our results suggest that offspring from obese dams
that are re-exposed to a HFD in adult life could present
a metabolic syndrome-like phenotype.
Besides others studies also had shown these increased
metabolic disturbances in adult offspring from obese
dams exposed to a HFD in adult [65], to our knowledge,
the present study was the first to show that maternal
diet leads to persistent modulation of key liver miRNAs
that may be involved in the development of insulin re-
sistance and NAFLD. Thus, the attention to maternal
diet during gestation and lactation seems to be of great
importance to avoid permanent changes during foetal
development that could contribute to the development
of obesity and its comorbidities in later life.
Conclusions
In summary, maternal HFD consumption during gesta-
tion and lactation affect the metabolic phenotype in the
offspring. The presence of fatty acids in maternal blood
and milk seem to be responsible for modulating the ex-
pression of liver miR-122 and miR-370, which are in-
volved in liver homeostasis. These findings provide
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important information regarding the effects of maternal
nutrition, especially during gestation, on the metabolic
phenotype of offspring. However, further studies are ne-
cessary to understand how nutritional intervention dur-
ing gestational and lactation periods can contribute to
reduce metabolic damage in offspring.
Additional files
Additional file 1: Figure S1. Antropometric and biochemical parameters
of dams at gestation and lactation. Body weight (A), adiposity (B), fasting
glucose (C), serum insulin (D) and lipids (CHOL and TAG - E) and total hepatic
lipid content (F) of control (C-D) and HFD (HF-D) dams in the gestational day
12, and lactational day 15. Values are means (n= 3-6) + - SEM. Student's t-test
was used in all analyses to compare C-D and HF-D groups in each period
(gestation or lactation). Different letters indicate statistical significance between
groups (p≤ 0.05). (JPG 667 kb)
Additional file 2: Figure S2. Characterization of d42 offspring from
control and obese dams prior to HFD exposure. Body weight (A), adiposity
(B), caloric intake (C), fasting glucose (D), serum insulin (E) and lipids (CHOL
and TAG - F), in d42 CC and HH groups. Values are means (n = 4-8) + - SEM.
Student's t-test was used in all analyses to compare CC and HH groups.
Different letters indicate statistical significance between groups (p≤ 0.05).
(JPG 390 kb)
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